top of page

UROwebinar: Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments POSTPONED (new date to follow soon)

eau
9/6/22, 9:30 PM
Europe/Berlin CET+2

Description

This webinar examines the most recent developments in the treatment of hormone-sensitive prostate cancer. It follows on from “Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice” held in April. In three talks, we will examine the role of treatment intensification, radioligand therapy and the personalized approach in mHSPC. The webinar will take approximately one hour and includes the possibility to ask questions during the Q&A.

 

This activity is supported by an educational grant with no involvement in the programme or speaker selection.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

S. Joniau

Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments POSTPONED (new date to follow soon)

Inglês

Description

Speakers

J. Buscombe, E. Efstathiou, S. Joniau

Speakers

Link to the Event

Banner to the Event

UROwebinar: Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments POSTPONED (new date to follow soon)
Link to Event
Banner
Registro
bottom of page